Company profile CGEM
After 39 days of this quarter the interest is at 67.0. Based on that we can calculate that during remaining 52 days it will total up to 156.0. Cullinan Oncology expected interest is significantly lower compared to same quarter last year (-59.4%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 0 | 135 inf% QoQ | 116 -14.1% QoQ | 97 -16.4% QoQ |
| 2020 | 192 inf% YoY 97.9% QoQ | 43 -68.1% YoY -77.6% QoQ | 230 98.3% YoY 434.9% QoQ | 110 13.4% YoY -52.2% QoQ |
| 2021 | 205 6.8% YoY 86.4% QoQ | 235 446.5% YoY 14.6% QoQ | 92 -60.0% YoY -60.9% QoQ | 91 -17.3% YoY -1.1% QoQ |
| 2022 | 258 25.9% YoY 183.5% QoQ | 334 42.1% YoY 29.5% QoQ | 180 95.7% YoY -46.1% QoQ | 227 149.5% YoY 26.1% QoQ |
| 2023 | 384 48.8% YoY 69.2% QoQ | 438 31.1% YoY 14.1% QoQ | 217 20.6% YoY -50.5% QoQ | 148 -34.8% YoY -31.8% QoQ |
| 2024 | 67 -82.6% YoY -54.7% QoQ | - | - | - |
The average 5 years interest of Cullinan Oncology was 14.56 per week. The last year interest of Cullinan Oncology compared to the last 5 years has changed by 38.8%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 202.09%.
Google Trends for CLN-081
Q4 +304.7% YoY, -19.8% QoQ | Q1 +17.2% YoY, +17.2% QoQ | Correlation: 0.16
After 39 days of this quarter the interest is at 56.0. Based on that we can calculate that during remaining 52 days it will total up to 131.0. CLN-081 expected interest is significantly higher compared to previous quarter (+44.0%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 134 | 25 -81.3% QoQ | 66 164.0% QoQ | 63 -4.5% QoQ |
| 2020 | 94 -29.9% YoY 49.2% QoQ | 32 28.0% YoY -66.0% QoQ | 39 -40.9% YoY 21.9% QoQ | 67 6.3% YoY 71.8% QoQ |
| 2021 | 66 -29.8% YoY -1.5% QoQ | 106 231.2% YoY 60.6% QoQ | 177 353.8% YoY 67.0% QoQ | 22 -67.2% YoY -87.6% QoQ |
| 2022 | 20 -69.7% YoY -9.1% QoQ | 133 25.5% YoY 565.0% QoQ | 206 16.4% YoY 54.9% QoQ | 52 136.4% YoY -74.8% QoQ |
| 2023 | 143 615.0% YoY 175.0% QoQ | 42 -68.4% YoY -70.6% QoQ | 88 -57.3% YoY 109.5% QoQ | 91 75.0% YoY 3.4% QoQ |
| 2024 | 56 -60.8% YoY -38.5% QoQ | - | - | - |
The average 5 years interest of CLN-081 was 6.6 per week. The last year interest of CLN-081 compared to the last 5 years has changed by -2.42%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by 6.27%.
After 39 days of this quarter the interest is at 100.0. Based on that we can calculate that during remaining 52 days it will total up to 233.0. Non-small cell lung cancer treatment expected interest is significantly higher compared to previous quarter (+108.0%) and same quarter last year (+441.9%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 17 | 39 129.4% QoQ | 26 -33.3% QoQ | 91 250.0% QoQ |
| 2020 | 59 247.1% YoY -35.2% QoQ | 84 115.4% YoY 42.4% QoQ | 93 257.7% YoY 10.7% QoQ | 36 -60.4% YoY -61.3% QoQ |
| 2021 | 17 -71.2% YoY -52.8% QoQ | 50 -40.5% YoY 194.1% QoQ | 95 2.2% YoY 90.0% QoQ | 44 22.2% YoY -53.7% QoQ |
| 2022 | 101 494.1% YoY 129.5% QoQ | 40 -20.0% YoY -60.4% QoQ | 42 -55.8% YoY 5.0% QoQ | 45 2.3% YoY 7.1% QoQ |
| 2023 | 43 -57.4% YoY -4.4% QoQ | 77 92.5% YoY 79.1% QoQ | 29 -31.0% YoY -62.3% QoQ | 112 148.9% YoY 286.2% QoQ |
| 2024 | 100 132.6% YoY -10.7% QoQ | - | - | - |
The average 5 years interest of Non-small cell lung cancer treatment was 4.75 per week. The last year interest of Non-small cell lung cancer treatment compared to the last 5 years has changed by 38.95%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 89.66%.
There is not enough data for CLN-049 clinical trial to provide analysis
There is not enough data for CLN-049 clinical trial to provide correlation calculation
There is not enough data for CLN-049 clinical trial to provide analysis
There is not enough data for CLN-619 solid tumor treatment to provide analysis
There is not enough data for CLN-619 solid tumor treatment to provide correlation calculation
There is not enough data for CLN-619 solid tumor treatment to provide analysis
There is not enough data for CLN-418 bispecific antibody to provide analysis
There is not enough data for CLN-418 bispecific antibody to provide correlation calculation
There is not enough data for CLN-418 bispecific antibody to provide analysis
There is not enough data for Cullinan Oncology careers to provide analysis
There is not enough data for Cullinan Oncology careers to provide correlation calculation
There is not enough data for Cullinan Oncology careers to provide analysis
There is not enough data for Cullinan Oncology reviews to provide analysis
There is not enough data for Cullinan Oncology reviews to provide correlation calculation
There is not enough data for Cullinan Oncology reviews to provide analysis
There is not enough data for Cullinan Oncology Massachusetts to provide analysis
There is not enough data for Cullinan Oncology Massachusetts to provide correlation calculation
There is not enough data for Cullinan Oncology Massachusetts to provide analysis
After 39 days of this quarter the interest is at 128.0. Based on that we can calculate that during remaining 52 days it will total up to 299.0. Cullinan Oncology -stock -company expected interest is significantly higher compared to previous quarter (+374.6%) and same quarter last year (+74.9%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 65 | 0 -100.0% QoQ | 95 inf% QoQ | 89 -6.3% QoQ |
| 2020 | 127 95.4% YoY 42.7% QoQ | 239 inf% YoY 88.2% QoQ | 54 -43.2% YoY -77.4% QoQ | 182 104.5% YoY 237.0% QoQ |
| 2021 | 236 85.8% YoY 29.7% QoQ | 153 -36.0% YoY -35.2% QoQ | 148 174.1% YoY -3.3% QoQ | 242 33.0% YoY 63.5% QoQ |
| 2022 | 220 -6.8% YoY -9.1% QoQ | 296 93.5% YoY 34.5% QoQ | 290 95.9% YoY -2.0% QoQ | 226 -6.6% YoY -22.1% QoQ |
| 2023 | 171 -22.3% YoY -24.3% QoQ | 273 -7.8% YoY 59.6% QoQ | 219 -24.5% YoY -19.8% QoQ | 63 -72.1% YoY -71.2% QoQ |
| 2024 | 128 -25.1% YoY 103.2% QoQ | - | - | - |
The average 5 years interest of Cullinan Oncology -stock -company was 13.47 per week. The last year interest of Cullinan Oncology -stock -company compared to the last 5 years has changed by 14.33%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 140.62%.